Current Grants Awarded to Faculty
-
Shanjana Awasthi, Ph.D.
Title of Project: "Surfactant protein-A regions as TLR4-immunomodulators"
- Sponsoring Agency: National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
- Time Period: 08/08/17 through 07/31/22
-
Vibhudutta Awasthi, Ph.D.
Title of Project: "Immunokinetics of superhydrophili polymer-modified liposome encapsulated hemoglobin"
- Sponsoring Agency: Oklahoma Center for the Advancement of Science and Technology (OCAST)
- Time Period: 09/01/17 through 08/31/20
Title of Project: "Pharmacotherapy of traumatic brain injury accompanied by hemorrhagic shock.""
- Sponsoring Agency: Department of Defense (DoD)
- Time Period: 09/30/17 through 09/29/20
-
Hibah Awwad, Ph.D.
Title of Project: "Histamine release in traumatic brain injury: Neurotoxic or neuroprotective?"
- Sponsoring Agency: American Association of Colleges of Pharmacy (AACP)
- Time Period: 01/01/17 through 12/31/17
-
Randle Gallucci, Ph.D.
Title of Project: "The role of IL-6 receptor in irritant dermatitis."
- Sponsoring Agency: National Institute of Occupational Safety and Health/NIH Center for Disease Control
- Time Period: 09/01/13 through 08/31/18
-
Michael Ihnat, Ph.D.
Title of Project: "Role of IL-6 and Stat3 in triple-negative breast cancer (TNBC) metastatic progression."
- Sponsoring Agency: Presbyterian Health Foundation
- Time Period: 01/11/17 through 01/10/18
-
Anne Kasus-Jacobi, Ph.D.
Title of Project: "Wound healing mechanisms modulated by novel antimicrobial peptides."
- Sponsoring Agency: Oklahoma Center for the Advancement of Science and Technology (OCAST)
- Time Period: 08/01/15 through 07/31/18
Title of Project: "Antibacterial activity of CAP37 peptides."
- Sponsoring Agency: Biolytx Corporation
- Time Period: 02/02/16 through 12/31/17
-
Shellie Keast, Ph.D., Pharm.D.
Title of Project: "Prescription opioid performance improvement metrics and heroin abuse"
- Sponsoring Agency: Oregon State University/Centers for Disease Control and Prevention (CDC)
- Time Period: 09/01/16 through 08/31/18
Title of Project: "DUR Foster Care collaboration development project for the State of Oklahoma"
- Sponsoring Agency: Oklahoma Health Care Authority (OHCA)
- Time Period: 07/01/16 through 09/30/17
Title of Project: "Drug utilization review board (DUR)"
- Sponsoring Agency: Oklahoma Health Care Authority (OHCA)
- Time Period: 07/01/17 through 06/30/18
Title of Project: "Research Fellowship Agreement"
- Sponsoring Agency: Purdue Pharma
- Time Period: 08/01/16 through 07/31/18
Title of Project: "SMINET - Applying evidence to improve care and outcomes in severe mental illness."
- Sponsoring Agency: Rutgers University
- Time Period: 07/01/16 through 06/30/18
-
William M. McShan, Ph.D.
Title of Project: "Phage-like chromosomal islands and virulence in pneumococci"
- Sponsoring Agency: NIH Center of Biomedical Research Excellence (CoBRE)/Oklahoma State University (OSU); Oklahoma Center for Respiratory and Infectious Diseases (OCRID)
- Time Period: 07/01/17 through 06/30/18
-
H. Anne Pereira, Ph.D.
Title of Project: "50th annual meeting of the Society for Leukocyte Biology (SLB)"
- Sponsoring Agency: National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID)
- Time Period: 06/20/17 through 05/31/18
-
R. Chris Rathbun, Pharm.D.
Title of Project: "HIV Drug Assistance Program (HDAP) to promote adherence."
- Sponsoring Agency: Oklahoma State Department of Health
- Time Period: 04/01/11 through 03/31/2018
-
Scott E. Schaeffer, D.Ph., DABAT
Title of Project:Â"Acute poisoning management and educational activities for Oklahoma"Sponsoring Agency:Oklahoma Department of Human Services (ODHS)Time Period:07/01/17 through 06/30/18
-
Kelly Standifer, Ph.D.
Title of Project:"Post-traumatic stress disorder and co-morbid chronic pain: Evidence that TNF initiates a sequelae involving nocioceptin/orphanin FQ"Sponsoring Agency:Oklahoma Center for the Advancement of Science and Technology (OCAST)Time Period:08/01/17 through 07/31/20
-
Sukyung Woo, Ph.D.
Title of Project: "Overcoming resistance to Anti-VEGT therapy with predictive modeling."
Sponsoring Agency: American Cancer Society (ACS)- Time Period: 07/01/16 through 06/30/20
-
Youngjae You, Ph.D.
Title of Project: "A synergistic combination therapy of photodynamic therapy and chemotherapy for breast cancer"
- Sponsoring Agency: Department of Defense (Idea Expansion)
- Time Period: 09/19/14 through 09/18/18
Title of Project: "Visible light-controlled combination strategy for treating nonmuscle invasive bladder cancers"
- Sponsoring Agency: Department of Defense (DoD)
- Time Period: 08/01/17 through 07/31/19
Title of Project: "Photo-unclick chemistry and its application to near infrared-activatable prodrugs"
- Sponsoring Agency: National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS)
- Time Period: 01/31/16 through 01/31/20
Title of Project: "NIR-activatable prodrugs for treating peritoneally metastasized ovarian cancers"
- Sponsoring Agency: National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)
- Time Period: 03/01/15 through 01/31/20
-
Wei Yue, Ph.D.
Title of Project:"Function and regulation of OATP1B3"Sponsoring Agency:National Institute of Health/National Institute of General Medical Sciences (NIH/NIGMS)Time Period:09/01/11 through 08/31/18
Title of Project:"AFPE Pre-doctoral fellowship for Alex Crow"Sponsoring Agency:American Foundation for Pharmaceutical Education (AFPE)Time Period:09/01/17 through 08/31/18